MedTrace Logo

The Effect of Norepinephrine on Cardiac Output in Patients Undergoing Liver Transplant .

NCT04376281 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2021-11-09

No results posted yet for this study

Summary

Early administration of NE in liver transplant recipient might enhance cardiac output through an increase in cardiac preload .

Conditions

  • Liver Transplantation

Interventions

DRUG

Noradrenaline

Noradrenaline infusion for patients undergoing liver transplantaion from living donor .

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Ahmed M Mukhtar, MD · professor

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-15
Primary Completion
2021-08-01
Completion
2021-10-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04376281 on ClinicalTrials.gov